Chloramphenicol eye drops containing borax or boric acid in children under 2 years: MHRA update
Posted 17 Nov 2021
Dr Anish Kotecha summarises the MHRA’s recent drug safety update, offering reassurance for continued use of these eye drops in children aged 0–2 years, based on the risk–benefit profile.
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.